Registrer deg | Logg på | FAQ      [?] 

Nøkkelord: prostate [312 articles]

Nye artikler klassifisert med nøkkelordet prostate.
  • Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.
    N Engl J Med, Vol. 351, No. 15. (7 October 2004), pp. 1502-1512.
    by IF Tannock, R de Wit, WR Berry, J Horti, A Pluzanska, KN Chi, S Oudard, C Théodore, ND James, I Turesson, MA Rosenthal, MA Eisenberger,
    posted to cancer cite fulltext hrpc prostate by zkyken on 2007-06-13 15:16:36 as ** along with 1 person zebkhan
  • notes The management of hormone refractory prostate cancer.
    Eur Urol, Vol. 29 Suppl 2 (1996), pp. 69-74.
    by DW Newling
    posted to cancer cite hrpc prostate by zkyken on 2007-06-13 15:03:39 as **
  • Cancer statistics, 1993.
    CA Cancer J Clin, Vol. 43, No. 1. (b 1993), pp. 7-26.
    by CC Boring, TS Squires, T Tong
    posted to cancer hrpc prostate by zkyken on 2007-06-13 15:01:36 as **
  • Natural history of progression after PSA elevation following radical prostatectomy.
    JAMA, Vol. 281, No. 17. (5 May 1999), pp. 1591-1597.
    by CR Pound, AW Partin, MA Eisenberger, DW Chan, JD Pearson, PC Walsh
    posted to cancer cite hrpc prostate by zkyken on 2007-06-13 15:10:27 as **
  • Methylation mediated silencing of TMS1/ASC gene in prostate cancer
    Molecular Cancer, Vol. 5 (18 July 2006), 28.
    by Partha M Das, Kavitha Ramachandran, Jane Vanwert, Larry Ferdinand, Gopal Gopisetty, Isildinha M Reis, Rakesh Singal
    posted to cancer methylation molecular prostate by zkyken on 2007-06-05 14:10:47 as **
  • Regulation of the Expression of the Prostate-specific Antigen by Claudin-7
    Journal of Membrane Biology, Vol. 194, No. 3. (1 July 2003), pp. 187-197.
    by Zheng, D Yu, M Foroohar, E Ko, J Chan, N Kim, R Chiu, S Pang
    posted to cancer gene prostate by zkyken on 2007-06-05 04:30:01 as **
  • Growth factors and their receptors: new targets for prostate cancer therapy.
    Urology, Vol. 58, No. 2 Suppl 1. (August 2001), pp. 114-122.
    by J Barton, G Blackledge, A Wakeling
    posted to cancer cite egfr prostate therapy by zkyken on 2007-06-13 15:52:20 as **
  • Differential expression of CD10 in prostate cancer and its clinical implication
    BMC Urology, Vol. 7 (02 March 2007), 3.
    by Marc A Dall'era, Lawrence D True, Andrew F Siegel, Michael P Porter, Tracy M Sherertz, Alvin Y Liu
    posted to cancer molecular prostate by zkyken on 2007-06-05 14:00:06 as **
  • Optimization of laser capture microdissection and RNA amplification for gene expression profiling of prostate cancer
    BMC Molecular Biology, Vol. 8 (21 March 2007), 25.
    by Dagmar M Kube, Dilara C Savci-Heijink, Anne-Francoise Lamblin, Farhad Kosari, George Vasmatzis, John C Cheville, Donald P Connelly, George G Klee
    posted to cancer molecular prostate by zkyken on 2007-06-05 13:57:34 as **
  • Non-hormonal systemic therapy in men with hormone-refractory prostate cancer and metastases: a systematic review from the Cancer Care Ontario Program in Evidence-based Care's Genitourinary Cancer Disease Site Group
    BMC Cancer, Vol. 6, No. 1. (2006)
    by Eric Winquist, Tricia Waldron, Scott Berry, Scott D Ernst, Sebastien Hotte, Himu Lukka
    posted to cancer molecular prostate by zkyken on 2007-06-05 14:09:10 as **
  • Prostate cancer: therapeutic, diagnostic, and basic studies.
    Lab Invest, Vol. 67, No. 5. (November 1992), pp. 540-552.
    by ME Stearns, T McGarvey
    posted to cancer cite diagnosis_treatment prostate by zkyken on 2007-06-13 16:19:40 as **
  • Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms
    Clin Cancer Res, Vol. 1, No. 5. (1 May 1995), pp. 545-550.
    by Hi Scher, A Sarkis, V Reuter, D Cohen, G Netto, D Petrylak, P Lianes, Z Fuks, J Mendelsohn, C Cordon-Cardo
    posted to cancer cite egfr fulltext prostate by zkyken on 2007-06-13 15:50:15 as **
  • Detection and clinical importance of micrometastatic disease.
    J Natl Cancer Inst, Vol. 91, No. 13. (7 July 1999), pp. 1113-1124.
    by K Pantel, RJ Cote, O Fodstad
    posted to cancer ctcs molecular prostate by zkyken on 2007-06-06 10:55:48 as ** along with 1 person adelgiglio
  • Novel expressed sequences identified in a model of androgen independent prostate cancer
    BMC Genomics, Vol. 8 (26 January 2007), 32.
    by Steven N Quayle, Heidi Hare, Allen D Delaney, Martin Hirst, Dorothy Hwang, Jacqueline E Schein, Steven JM Jones, Marco A Marra, Marianne D Sadar
    posted to cancer molecular prostate by zkyken on 2007-06-05 14:02:35 as ** along with 1 person xingxu
  • Finding prostate cancer susceptibility genes.
    Annu Rev Genomics Hum Genet, Vol. 5 (2004), pp. 151-175.
    by EA Ostrander, K Markianos, JL Stanford
    posted to cancer prostate by ziquje on 2005-05-10 22:50:45 as **
  • Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing.
    Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 14, No. 11. (1 June 2008), pp. 3254-3261.
    by KS Sfanos, TC Bruno, CH Maris, L Xu, CJ Thoburn, AM DeMarzo, AK Meeker, WB Isaacs, CG Drake
    posted to tregs thesis th17 prostate progression cancer by Zephyrus on 2008-09-18 16:21:29 as **
  • The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis.
    Cancer research, Vol. 61, No. 22. (15 November 2001), pp. 8143-8149.
    by JL Phillips, SW Hayward, Y Wang, J Vasselli, C Pavlovich, H Padilla-Nash, JR Pezullo, BM Ghadimi, GD Grossfeld, A Rivera, WM Linehan, GR Cunha, T Ried
    posted to 20q cell_line prostate by YuvalTabach on 2008-08-23 14:08:53 as **
  • Identification of ETS-like transcription factor 4 as a novel androgen receptor target in prostate cancer cells
    Oncogene, Vol. aop, No. current.
    by H Makkonen, T Jääskeläinen, T Pitkänen-Arsiola, M Rytinki, KK Waltering, M Mättö, T Visakorpi, JJ Palvimo
    posted to ar ets prostate by YuvalTabach on 2008-08-24 20:43:42 as **
  • Pharmacokinetic parameters as a potential predictor of response to pharmacotherapy in benign prostatic hyperplasia: a preclinical trial using dynamic contrast-enhanced MRI
    Magnetic Resonance Imaging, Vol. 24, No. 6. (July 2006), pp. 721-725.
    by Guang Jia, Johannes T Heverhagen, Hannes Henry, Hans Polzer, Klaus T Baudendistel, Hendrik von Tengg-Kobligk, Andrea L Levine, Thomas J Rosol, Michael V Knopp
    posted to dce-mri oncology prostate by xtizon on 2006-07-21 09:51:30 as *****
  • Flow cytometry, MRI, PET and NMR spectroscopy methods of non-invasive drug monitoring in prostate tumor
    Computer-Based Medical Systems, 2003. Proceedings. 16th IEEE Symposium (2003), pp. 263-268.
    by R Sharma, R Kline
    posted to cancer medical_imaging prostate by xtizon on 2006-12-08 13:39:51 as *****
  • [18F]fluorocholine PET/CT in the assessment of bone metastases in prostate cancer
    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, No. 8. (2007), pp. 1316-1317.
    by Mohsen Beheshti, Reza Vali, Werner Langsteger
    posted to cancer fluorocholine metastasis pet pet-ct prostate by xtizon on 2007-08-27 15:32:16 as **
  • [11C]Choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy
    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, No. 9. (2008), pp. 1740-1741.
    by Sven Reske
    posted to choline pet prostate by xtizon on 2008-08-27 07:02:32 as ** along with 1 group Positron-Emission-Tomography
  • Vascular Differences Detected by MRI for Metastatic Versus Nonmetastatic Breast and Prostate Cancer Xenografts
    pp. 143-153.
    by ZM Bhujwalla
    posted to breast prostate mri tumor vascularization by xtizon on 2007-01-09 08:40:47 as **
  • Biomarker expression patterns that correlate with high grade features in treatment naive, organ-confined prostate cancer
    BMC Medical Genomics, Vol. 1, No. 1. (2008)
    by Timothy Mcdonnell, Nikhil Chari, Jeong C Vega, Patricia Troncoso, Xuemei Wang, Carlos B Ramos, Kevin Coombes, Shawn Brisbay, Remigio Lopez, George Prendergast, Christopher Logothetis, Kim A Do
    posted to cancer gleason prostate tissue-microarray by xtizon on 2008-02-13 15:06:05 as ***
  • Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma: Correlation with stepwise histopathology
    Journal of Magnetic Resonance Imaging, Vol. 27, No. 1. (2008), pp. 132-139.
    by Kengo Yoshimitsu, Keijiro Kiyoshima, Hiroyuki Irie, Tsuyoshi Tajima, Yoshiki Asayama, Masakazu Hirakawa, Kousei Ishigami, Seiji Naito, Hiroshi Honda
    posted to diagnosis dw-mri histology prostate apparent-diffusion-coefficient by xtizon on 2008-01-09 20:55:48 as ***
  • Prostate Cancer Localization with Dynamic Contrast-enhanced MR Imaging and Proton MR Spectroscopic Imaging
    Radiology, Vol. 241, No. 2. (1 November 2006), pp. 449-458.
    by Jurgen J Futterer, Stijn W Heijmink, Tom W Scheenen, Jeroen Veltman, Henkjan J Huisman, Pieter Vos, Christina A de Kaa, Alfred J Witjes, Paul F Krabbe, Arend Heerschap, Jelle O Barentsz
    posted to dce-mri mr-spectro prostate by xtizon on 2007-02-14 09:03:47 as ***** along with 1 person sparfait
  • Differentiation of nonmetastatic and metastatic rodent prostate tumors with high spectral and spatial resolution MRI.
    Magn Reson Med, Vol. 45, No. 6. (June 2001), pp. 1046-1055.
    by X Fan, JN River, M Zamora, K Tarlo, K Kellar, C Rinker-Schaeffer, GS Karczmar
    posted to cancer mri prostate rodent spectroscopy tumor by xtizon on 2007-09-24 12:54:07 as *****
  • Current Role and Future Perspectives of Magnetic Resonance Spectroscopy in Radiation Oncology for Prostate Cancer
    Neoplasia, Vol. 9, No. 6. (June 2007), pp. 455-463.
    by Zapotoczna, Aleksandra, Sasso, Giuseppe, Simpson, John, Roach, Mack
    posted to cancer mri mrs prostate spectroscopy by xtizon on 2007-07-28 22:29:11 as *****
  • Correlation between metabolite ratios and ADC values of prostate in men with increased PSA level
    Magnetic Resonance Imaging, Vol. 24, No. 5. (June 2006), pp. 541-548.
    by Virendra Kumar, Naranamangalam R Jagannathan, Rajeev Kumar, Sharat C Das, Lokesh Jindal, Sanjay Thulkar, Siddhartha D Gupta, Sadanand N Dwivedi, Stefan Roell, Ashok K Hemal, Narmada P Gupta
    posted to dw-mri prostate psa by xtizon on 2007-12-17 21:27:45 as *****
  • Accurate estimation of pharmacokinetic contrast-enhanced dynamic MRI parameters of the prostate
    Journal of Magnetic Resonance Imaging, Vol. 13, No. 4. (2001), pp. 607-614.
    by Henkjan J Huisman, Marc R Engelbrecht, Jelle O Barentsz
    posted to analysis dce-mri prostate by xtizon on 2006-07-21 09:45:46 as *****
  • In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging
    Journal of Magnetic Resonance Imaging, Vol. 16, No. 2. (2002), pp. 196-200.
    by Bashar Issa
    posted to dw-mri epi prostate by xtizon on 2007-12-17 21:37:31 as *****
  • Evaluation of [18F]-choline PET/CT for staging and restaging of prostate cancer
    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, No. 2. (19 February 2008), pp. 253-263.
    by Daniela Husarik, Raymond Miralbell, Markus Dubs, Hubert John, Olivier Giger, Albert Gelet, Tibor Cservenyàk, Thomas Hany
    posted to cancer pet prostate by xtizon on 2008-02-07 15:38:27 as **** along with 1 group Positron-Emission-Tomography
  • Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis - Correlation with biopsy and histopathology
    Journal of Magnetic Resonance Imaging, Vol. 24, No. 1. (2006), pp. 108-113.
    by Piotr Kozlowski, Silvia D Chang, Edward C Jones, Kenneth W Berean, Henry Chen, Larry S Goldenberg
    posted to dce-mri dw-mri oncology prostate by xtizon on 2006-07-21 09:48:09 as ***** along with 1 person decraene
  • Continuous Low-Dose (Metronomic) Chemotherapy on Rat Prostate Tumors Evaluated Using MRI In Vivo and Comparison with Histology
    Neoplasia, Vol. 7, No. 7. (July 2005), pp. 678-687.
    by Dawen Zhao, Lan Jiang, Eric W Hahn, Ralph P Mason
    posted to tumor prostate mri histology by xtizon on 2007-01-10 08:35:30 as **
  • Dynamic Contrast-Enhanced MRI for Preoperative Identification of Localised Prostate Cancer
    European Urology Supplements, Vol. 6, No. 8. (March 2007), pp. 525-532.
    by Arnauld Villers, Philippe Puech, Xavier Leroy, Jacques Biserte, Jean-Christophe Fantoni, Laurent Lemaitre
    posted to clinical dce-mri prostate by xtizon on 2007-11-13 11:56:18 as ****
  • Multifeature Prostate Cancer Diagnosis and Gleason Grading of Histological Images
    Medical Imaging, IEEE Transactions on, Vol. 26, No. 10. (2007), pp. 1366-1378.
    by A Tabesh, M Teverovskiy, HY Pang, VP Kumar, D Verbel, A Kotsianti, O Saidi
    posted to classification gleason histology k-nn microscopy prostate svm by xtizon on 2007-10-07 08:22:52 as ***
  • Three-Dimensional Magnetic Resonance Spectroscopic Imaging of Brain and Prostate Cancer
    by J Kurhanewicz
    posted to prostate mrs brain by xtizon on 2007-01-10 08:33:23 as **
  • Prostate Cancer: Evaluation of Vascular Characteristics with Dynamic Contrast-enhanced T1-weighted MR Imaging--Initial Experience
    Radiology, Vol. 233, No. 3. (1 December 2004), pp. 709-715.
    by David L Buckley, Caleb Roberts, Geoff J Parker, John P Logue, Charles E Hutchinson
    posted to cancer dce-mri prostate by xtizon on 2008-05-06 09:48:34 as *****
  • Magnetic resonance spectroscopy detects metabolic differences between seven dunning rat prostate tumor sublines with different biological behavior
    The Prostate, Vol. 25, No. 1. (1994), pp. 19-28.
    by EB Cornel, A Heerschap, GAHJ Smits, GON Oosterhof, FMJ Debruyne, JA Schalken
    posted to mrs prostate by xtizon on 2007-12-11 16:00:01 as ****
  • Impact of stroma on the growth, microcirculation, and metabolism of experimental prostate tumors.
    Neoplasia, Vol. 9, No. 1. (January 2007), pp. 57-67.
    by CM Zechmann, EC Woenne, G Brix, N Radzwill, M Ilg, P Bachert, P Peschke, S Kirsch, HU Kauczor, S Delorme, W Semmler, F Kiessling
    posted to cancer prostate rodent tumor by xtizon on 2007-09-24 12:49:50 as *****
  • Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Localization of Recurrent Prostate Cancer After External Beam Radiotherapy
    International Journal of Radiation Oncology*Biology*Physics, Vol. 70, No. 2. (1 February 2008), pp. 425-430.
    by Masoom A Haider, Peter Chung, Joan Sweet, Ants Toi, Kartik Jhaveri, Cynthia Menard, Padraig Warde, John Trachtenberg, Gina Lockwood, Michael Milosevic
    posted to dce-mri diagnosis prostate radiotherapy by xtizon on 2008-02-12 09:33:17 as ****
  • In vivo MRI volumetric measurement of prostate regression and growth in mice
    BMC Urology, Vol. 7 (24 July 2007), 12.
    by Kent L Nastiuk, Hui Liu, Mark Hamamura, Tugan L Muftuler, Orhan Nalcioglu, John J Krolewski
    posted to measurement mouse mri prostate by xtizon on 2007-09-24 12:46:09 as ****
  • [11C]Choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy
    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, No. 6. (14 June 2008), pp. 1065-1073.
    by Giampiero Giovacchini, Maria Picchio, Elisa Coradeschi, Vincenzo Scattoni, Valentino Bettinardi, Cesare Cozzarini, Massimo Freschi, Ferruccio Fazio, Cristina Messa
    posted to choline pet prostate psa by xtizon on 2008-05-18 17:02:15 as *****
  • Peripheral zone prostate cancer: accuracy of different interpretative approaches with MR and MR spectroscopic imaging.
    Radiology, Vol. 246, No. 1. (January 2008), pp. 177-184.
    by AC Westphalen, FV Coakley, A Qayyum, M Swanson, JP Simko, Y Lu, S Zhao, PR Carroll, BM Yeh, J Kurhanewicz
    posted to cancer mr-spectro prostate by xtizon on 2008-05-16 08:07:50 as ***** along with 1 person kurig0han
  • Dynamic Contrast-Enhanced MRI of Prostate Cancer at 3 T: A Study of Pharmacokinetic Parameters
    Am. J. Roentgenol., Vol. 189, No. 4. (1 October 2007), pp. W192-201.
    by Iclal Ocak, Marcelino Bernardo, Greg Metzger, Tristan Barrett, Peter Pinto, Paul S Albert, Peter L Choyke
    posted to 3t clinical dce-mri prostate by xtizon on 2007-11-13 11:55:03 as *****
  • Prediction of seminal vesicle invasion in prostate cancer: incremental value of adding endorectal MR imaging to the Kattan nomogram.
    Radiology, Vol. 242, No. 1. (January 2007), pp. 182-188.
    by L Wang, H Hricak, MW Kattan, HN Chen, K Kuroiwa, HF Eisenberg, PT Scardino
    posted to mri prostate by xtizon on 2007-02-14 11:55:31 as *****
  • Characterizing Vascular Parameters in Hypoxic Regions: A Combined Magnetic Resonance and Optical Imaging Study of a Human Prostate Cancer Model
    Cancer Res, Vol. 66, No. 20. (15 October 2006), pp. 9929-9936.
    by Venu Raman, Dmitri Artemov, Arvind P Pathak, Paul T Winnard, Stephen Mcnutt, Anna Yudina, Alexei Bogdanov, Zaver M Bhujwalla
    posted to hypoxia mri optical prostate tumor vascularization by xtizon on 2007-01-09 08:44:09 as ** along with 1 person Garamonfok
  • Prostate Cancer Tumor Grade Differentiation with Dynamic Contrast-enhanced MR Imaging in the Rat: Comparison of Macromolecular and Small-Molecular Contrast Media-Preliminary Experience
    Radiology, Vol. 213, No. 1. (1 October 1999), pp. 265-272.
    by Axel Gossmann, Yoshitaka Okuhata, David M Shames, Thomas H Helbich, Timothy P Roberts, Michael F Wendland, Sabine Huber, Robert C Brasch
    posted to dce-mri macromolecular prostate by xtizon on 2007-07-23 13:40:36 as *****
  • New model for analysis of dynamic contrast-enhanced MRI data distinguishes metastatic from nonmetastatic transplanted rodent prostate tumors
    Magnetic Resonance in Medicine, Vol. 51, No. 3. (2004), pp. 487-494.
    by Xiaobing Fan, Milica Medved, Jonathan N River, Marta Zamora, Claire Corot, Philippe Robert, Philippe Bourrinet, Martin Lipton, Rita M Culp, Gregory S Karczmar
    posted to cancer dce-mri model prostate rodent by xtizon on 2007-10-24 21:55:27 as *****
  • Differentiation of prostate cancer from normal prostate tissue in an animal model: conventional MRI and dynamic contrast-enhanced MRI.
    Rofo, Vol. 177, No. 7. (July 2005), pp. 935-939.
    by O Gemeinhardt, L Lüdemann, D Prochnow, C Abramjuk, M Taupitz, B Hamm, D Beyersdorff
    posted to cancer dce-mri mri prostate rodent by xtizon on 2007-09-24 12:51:37 as *****
    • NB: Du kan sitere denne siden som: http://www.citeulike.org/tag/prostate

    Result page: 1 2 3 4 5 6 7 Next RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.